Xinxin Si

1.4k total citations
48 papers, 1.0k citations indexed

About

Xinxin Si is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Xinxin Si has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Cancer Research. Recurrent topics in Xinxin Si's work include RNA modifications and cancer (7 papers), Computational Drug Discovery Methods (6 papers) and Cancer-related molecular mechanisms research (5 papers). Xinxin Si is often cited by papers focused on RNA modifications and cancer (7 papers), Computational Drug Discovery Methods (6 papers) and Cancer-related molecular mechanisms research (5 papers). Xinxin Si collaborates with scholars based in China, United States and Australia. Xinxin Si's co-authors include Erbao Zhang, Jinfei Chen, Liang Han, Dandan Yin, Xuezhi He, Wei De, Tongpeng Xu, Lin Xu, Mantang Qiu and Jun Su and has published in prestigious journals such as Nucleic Acids Research, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Xinxin Si

41 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinxin Si China 12 830 616 85 67 59 48 1.0k
Guang Zhang China 20 648 0.8× 365 0.6× 29 0.3× 112 1.7× 44 0.7× 49 985
Emre Özdemir Denmark 10 968 1.2× 493 0.8× 150 1.8× 110 1.6× 29 0.5× 21 1.2k
Maryam Ranjbar Iran 11 418 0.5× 230 0.4× 49 0.6× 34 0.5× 33 0.6× 19 635
Yicheng Zhao China 17 595 0.7× 189 0.3× 57 0.7× 55 0.8× 28 0.5× 62 959
Xianguang Yang China 13 457 0.6× 163 0.3× 56 0.7× 51 0.8× 23 0.4× 47 836
Tian Zhou China 16 383 0.5× 204 0.3× 34 0.4× 65 1.0× 19 0.3× 32 617
Abdel Hady A. Abdel Wahab Egypt 18 352 0.4× 233 0.4× 25 0.3× 105 1.6× 26 0.4× 48 688
Jian Ding China 16 973 1.2× 887 1.4× 16 0.2× 119 1.8× 31 0.5× 38 1.3k

Countries citing papers authored by Xinxin Si

Since Specialization
Citations

This map shows the geographic impact of Xinxin Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinxin Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinxin Si more than expected).

Fields of papers citing papers by Xinxin Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinxin Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinxin Si. The network helps show where Xinxin Si may publish in the future.

Co-authorship network of co-authors of Xinxin Si

This figure shows the co-authorship network connecting the top 25 collaborators of Xinxin Si. A scholar is included among the top collaborators of Xinxin Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinxin Si. Xinxin Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Hongwei, et al.. (2025). Machine Learning‐Based Discovery of a Novel Noncovalent MurA Inhibitor as an Antibacterial Agent. Chemical Biology & Drug Design. 105(3). e70084–e70084.
2.
Si, Xinxin, Zhen Lü, Tian Zhong, et al.. (2025). Mechanisms of fatigue and molecular diagnostics: The application of bioactive compounds in fatigue relief research. Food Bioscience. 68. 106523–106523.
3.
Xia, Jie, et al.. (2025). Discovery of Novel FtsZ Inhibitors With Antimicrobial Activity by Virtual Screening and In Vitro Biological Evaluation. Chemistry & Biodiversity. 22(6). e202403042–e202403042. 1 indexed citations
4.
Liu, Wei, Xinxin Si, Jiaxing Liang, et al.. (2024). Multi-omic characterization of air pollution effects: Applications of AirSigOmniTWP Hub. Ecotoxicology and Environmental Safety. 284. 116939–116939. 2 indexed citations
5.
Guo, Tingting, Yaling Wang, Hongwei Jin, et al.. (2024). Discovery of a novel chemotype as DYRK1A inhibitors against Alzheimer's disease: Computational modeling and biological evaluation. International Journal of Biological Macromolecules. 269(Pt 1). 132024–132024. 4 indexed citations
6.
Yang, Ting, et al.. (2024). A landscape of metabolic variation among clinical outcomes of peritoneal dialysis in end-stage renal disease. Clinica Chimica Acta. 555. 117826–117826. 2 indexed citations
7.
Li, Yu, et al.. (2024). Identification of SMC2 and SMC4 as prognostic markers in breast cancer through bioinformatics analysis. Clinical & Translational Oncology. 26(12). 2952–2965.
9.
Zhu, Zihao, Tianlei Li, Wenxuan Zhang, et al.. (2023). Discovery of isatin-β-methyldithiocarbazate derivatives as New Delhi metallo- β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates. Biomedicine & Pharmacotherapy. 166. 115439–115439. 6 indexed citations
11.
Xue, Yong, Yan Wang, Xinxin Si, et al.. (2023). Rapid and accurate genotyping of human SNP rs671 in aldehyde dehydrogenase 2 gene using one-step CRISPR/Cas12b assay without DNA amplification. Cell Division. 18(1). 14–14. 2 indexed citations
12.
Zhang, Quan, et al.. (2023). Biomaterial-assisted tumor therapy: A brief review of hydroxyapatite nanoparticles and its composites used in bone tumors therapy. Frontiers in Bioengineering and Biotechnology. 11. 1167474–1167474. 7 indexed citations
13.
Si, Xinxin, Shuai Zhang, Yong Liu, et al.. (2023). Effect of grain/bran crude extract from Fagopyrum tataricum on hypoglycemic activity of type 2 diabetes mice and study on molecular mechanism of treatment. Cogent Food & Agriculture. 9(1). 3 indexed citations
14.
He, Chengwei, Xiao Shi, Xinxin Si, et al.. (2022). A Novel ATM Antisense Transcript ATM-AS Positively Regulates ATM Expression in Normal and Breast Cancer Cells. Current Medical Science. 42(4). 681–691. 5 indexed citations
15.
Si, Xinxin, et al.. (2022). LncRNA DDX11-AS1 Promotes Chemoresistance through LIN28A-Mediated ATG12 mRNA Stabilization in Breast Cancer. Pharmacology. 108(1). 61–73. 12 indexed citations
16.
Si, Xinxin, Xiao Zhang, Tingting Xiao, et al.. (2022). Highly sensitive genotyping of MTHFR C677T polymorphisms using a novel RPA-LDR-qPCR assay. Acta Biochimica et Biophysica Sinica. 54(11). 1753–1756. 1 indexed citations
17.
Zhang, Erbao, Xuezhi He, Chongguo Zhang, et al.. (2018). A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome biology. 19(1). 154–154. 221 indexed citations
18.
Zhang, Erbao, Liang Han, Dandan Yin, et al.. (2016). H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma. Nucleic Acids Research. 45(6). 3086–3101. 268 indexed citations
19.
Zhang, Ruijun, et al.. (2014). Analysis of resonance reliability for synchronous-belt transmission with transverse vibration. Journal of Vibroengineering. 16(2). 891–900. 2 indexed citations
20.
Shi, Junfeng, Xingjia Li, Xinxin Si, et al.. (2012). ERα positively regulated DNMT1 expression by binding to the gene promoter region in human breast cancer MCF-7 cells. Biochemical and Biophysical Research Communications. 427(1). 47–53. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026